Clinical Trial Update: Dose-Escalated Hypofractionated Adaptive Radiotherapy for Head and Neck Cancer [Phase 1]

View source ↗

Summary

This Phase 1 study investigates dose-escalated hypofractionated adaptive radiotherapy for head and neck cancer and has completed with results posted on 2025-07-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Head and Neck Neoplasm | Phase 1 | Status: COMPLETED | Results posted: 2025-07-15